SILOAM INTL HOS. RP 125
Research SILOAM INTL HOS. RP 125 (2LS) on Bullrun: market cap EUR 1.30B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2LS
- ExchangeF
- CountryIndonesia
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyEUR
- Market capEUR 1.30B
- Financial periodQ1 2026
- RevenueIDR 3.28T
- Net incomeIDR 279.97B
- Free cash flowIDR 86.86B
- Gross margin38.2%
Valuation Snapshot
latest market cap is EUR 1.30B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 1.30B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About SILOAM INTL HOS. RP 125
PT Siloam International Hospitals Tbk operates hospitals and clinics in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; and vaccine and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID-19 tests; radiation therapy; and teleconsultation services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SILOAM INTL HOS. RP 125's market cap?
SILOAM INTL HOS. RP 125's market capitalization is EUR 1.30B.
What does SILOAM INTL HOS. RP 125 do?
PT Siloam International Hospitals Tbk operates hospitals and clinics in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; and vaccine and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID-19 tests; radiation therapy; and teleconsultation services.